Arcoma

Arcoma EBITDA per Share

The EBITDA per Share of Arcoma (ARCOMA.ST) as of Oct 24, 2026 is 0.61 SEK. In the previous year, EBITDA per Share was 1.61 SEK — a change of -62.42% (lower).

EBITDA per Share

0.61SEK

YoY

-62.42%

Last updated:

EBITDA per Share of Arcoma is 2025 0.61 SEK. EBITDA per Share of Arcoma was 2024 1.61 SEK. It decreases by -62.42% lower compared to the previous year.

The Arcoma EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.30 SEK
Jan 1, 2019
0.93 SEK
Jan 1, 2020
0.33 SEK
Jan 1, 2021
-0.26 SEK
Jan 1, 2022
0.64 SEK
Jan 1, 2023
0.86 SEK
Jan 1, 2024
1.61 SEK
Jan 1, 2025
0.61 SEK
The Arcoma EBITDA per Share history
YEAREBITDA per ShareYoY
0.61SEK-62.42%
1.61SEK+88.59%
0.86SEK+34.71%
0.64SEK-343.84%
-0.26SEK-178.41%
0.33SEK-64.24%
0.93SEK+212.47%
0.30SEK-175.54%
-0.39SEK-2.17%
-0.40SEK-13,673.02%
0.00SEK-97.97%
0.15SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

EBITDA per Share of Arcoma is 0.61 SEK in 2025.

EBITDA per Share of Arcoma changed from 1.61 SEK to 0.61 SEK, representing a -62.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Arcoma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Arcoma

All Key Metrics — Arcoma